EP3656443
USE OF TRL AGONIST AND ANTI-CD47 AGENT TO ENHANCE PHAGOCYTOSIS OF CANCER CELLS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
21.1.2016EP published:
29.9.2021EP application number:
19197485.6
EPO information:
European Patent Register
Max expiry date:
20.1.2036
Title:
USE OF TRL AGONIST AND ANTI-CD47 AGENT TO ENHANCE PHAGOCYTOSIS OF CANCER CELLS
Timeline
Today
21.1.2016EP application
29.9.2021EP Publication
Owner
Name:
The Board of Trustees of the Leland Stanford Junior UniversityAddress:
Office of the General Counsel Building 170, Third Floor, Main Quad P.O. Box 20386, Stanford, CA 94305-2038, US
Inventor
Name:
WEISSMAN, Irving L.Address:
Stanford, CA California 94305, US
Name:
FENG, MingyeAddress:
Mountain View, CA California 94040, US
Name:
VOLKMER, Jens-PeterAddress:
Menlo Park, CA California 94025, US
Priority
Number:
201562106050 PDate:
21.1.2015Country:
US
Classification
Categories:
A61K 39/39, A61K 39/395, A61K 45/06, A61K 31/4745, A61K 31/713, A61K 35/15, A61P 7/00, A61P 35/00, C07K 16/18, C07K 16/28, A61K 31/519